Profile: Katherine Bowdish, Sanofi’s Early Science Investment Scout

 
• By Lucie Ellis-Taitt

Katherine Bowdish, vice president of global R&D at Sanofi and leader of Sunrise, the French big pharma's early-stage investment arm, talks to Scrip about living vicariously through biotech companies whilst having the power and backing of a pharma major to advance important, innovative science.

Rollercoaster
Riding the early science rollercoaster is not for the fainthearted • Source: Shutterstock

More from Start-Ups & SMEs

More from Business